Islet sympathetic innervation and islet neuropathology in patients with type 1 diabetes

Abstract Dysregulation of glucagon secretion in type 1 diabetes (T1D) involves hypersecretion during postprandial states, but insufficient secretion during hypoglycemia. The sympathetic nervous system regulates glucagon secretion. To investigate islet sympathetic innervation in T1D, sympathetic tyro...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Martha Campbell-Thompson, Elizabeth A. Butterworth, J. Lucas Boatwright, Malavika A. Nair, Lith H. Nasif, Kamal Nasif, Andy Y. Revell, Alberto Riva, Clayton E. Mathews, Ivan C. Gerling, Desmond A. Schatz, Mark A. Atkinson
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/06c0546e7343448f81538ebc42c845a0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:06c0546e7343448f81538ebc42c845a0
record_format dspace
spelling oai:doaj.org-article:06c0546e7343448f81538ebc42c845a02021-12-02T16:35:56ZIslet sympathetic innervation and islet neuropathology in patients with type 1 diabetes10.1038/s41598-021-85659-82045-2322https://doaj.org/article/06c0546e7343448f81538ebc42c845a02021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-85659-8https://doaj.org/toc/2045-2322Abstract Dysregulation of glucagon secretion in type 1 diabetes (T1D) involves hypersecretion during postprandial states, but insufficient secretion during hypoglycemia. The sympathetic nervous system regulates glucagon secretion. To investigate islet sympathetic innervation in T1D, sympathetic tyrosine hydroxylase (TH) axons were analyzed in control non-diabetic organ donors, non-diabetic islet autoantibody-positive individuals (AAb), and age-matched persons with T1D. Islet TH axon numbers and density were significantly decreased in AAb compared to T1D with no significant differences observed in exocrine TH axon volume or lengths between groups. TH axons were in close approximation to islet α-cells in T1D individuals with long-standing diabetes. Islet RNA-sequencing and qRT-PCR analyses identified significant alterations in noradrenalin degradation, α-adrenergic signaling, cardiac β-adrenergic signaling, catecholamine biosynthesis, and additional neuropathology pathways. The close approximation of TH axons at islet α-cells supports a model for sympathetic efferent neurons directly regulating glucagon secretion. Sympathetic islet innervation and intrinsic adrenergic signaling pathways could be novel targets for improving glucagon secretion in T1D.Martha Campbell-ThompsonElizabeth A. ButterworthJ. Lucas BoatwrightMalavika A. NairLith H. NasifKamal NasifAndy Y. RevellAlberto RivaClayton E. MathewsIvan C. GerlingDesmond A. SchatzMark A. AtkinsonNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-17 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Martha Campbell-Thompson
Elizabeth A. Butterworth
J. Lucas Boatwright
Malavika A. Nair
Lith H. Nasif
Kamal Nasif
Andy Y. Revell
Alberto Riva
Clayton E. Mathews
Ivan C. Gerling
Desmond A. Schatz
Mark A. Atkinson
Islet sympathetic innervation and islet neuropathology in patients with type 1 diabetes
description Abstract Dysregulation of glucagon secretion in type 1 diabetes (T1D) involves hypersecretion during postprandial states, but insufficient secretion during hypoglycemia. The sympathetic nervous system regulates glucagon secretion. To investigate islet sympathetic innervation in T1D, sympathetic tyrosine hydroxylase (TH) axons were analyzed in control non-diabetic organ donors, non-diabetic islet autoantibody-positive individuals (AAb), and age-matched persons with T1D. Islet TH axon numbers and density were significantly decreased in AAb compared to T1D with no significant differences observed in exocrine TH axon volume or lengths between groups. TH axons were in close approximation to islet α-cells in T1D individuals with long-standing diabetes. Islet RNA-sequencing and qRT-PCR analyses identified significant alterations in noradrenalin degradation, α-adrenergic signaling, cardiac β-adrenergic signaling, catecholamine biosynthesis, and additional neuropathology pathways. The close approximation of TH axons at islet α-cells supports a model for sympathetic efferent neurons directly regulating glucagon secretion. Sympathetic islet innervation and intrinsic adrenergic signaling pathways could be novel targets for improving glucagon secretion in T1D.
format article
author Martha Campbell-Thompson
Elizabeth A. Butterworth
J. Lucas Boatwright
Malavika A. Nair
Lith H. Nasif
Kamal Nasif
Andy Y. Revell
Alberto Riva
Clayton E. Mathews
Ivan C. Gerling
Desmond A. Schatz
Mark A. Atkinson
author_facet Martha Campbell-Thompson
Elizabeth A. Butterworth
J. Lucas Boatwright
Malavika A. Nair
Lith H. Nasif
Kamal Nasif
Andy Y. Revell
Alberto Riva
Clayton E. Mathews
Ivan C. Gerling
Desmond A. Schatz
Mark A. Atkinson
author_sort Martha Campbell-Thompson
title Islet sympathetic innervation and islet neuropathology in patients with type 1 diabetes
title_short Islet sympathetic innervation and islet neuropathology in patients with type 1 diabetes
title_full Islet sympathetic innervation and islet neuropathology in patients with type 1 diabetes
title_fullStr Islet sympathetic innervation and islet neuropathology in patients with type 1 diabetes
title_full_unstemmed Islet sympathetic innervation and islet neuropathology in patients with type 1 diabetes
title_sort islet sympathetic innervation and islet neuropathology in patients with type 1 diabetes
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/06c0546e7343448f81538ebc42c845a0
work_keys_str_mv AT marthacampbellthompson isletsympatheticinnervationandisletneuropathologyinpatientswithtype1diabetes
AT elizabethabutterworth isletsympatheticinnervationandisletneuropathologyinpatientswithtype1diabetes
AT jlucasboatwright isletsympatheticinnervationandisletneuropathologyinpatientswithtype1diabetes
AT malavikaanair isletsympatheticinnervationandisletneuropathologyinpatientswithtype1diabetes
AT lithhnasif isletsympatheticinnervationandisletneuropathologyinpatientswithtype1diabetes
AT kamalnasif isletsympatheticinnervationandisletneuropathologyinpatientswithtype1diabetes
AT andyyrevell isletsympatheticinnervationandisletneuropathologyinpatientswithtype1diabetes
AT albertoriva isletsympatheticinnervationandisletneuropathologyinpatientswithtype1diabetes
AT claytonemathews isletsympatheticinnervationandisletneuropathologyinpatientswithtype1diabetes
AT ivancgerling isletsympatheticinnervationandisletneuropathologyinpatientswithtype1diabetes
AT desmondaschatz isletsympatheticinnervationandisletneuropathologyinpatientswithtype1diabetes
AT markaatkinson isletsympatheticinnervationandisletneuropathologyinpatientswithtype1diabetes
_version_ 1718383673990971392